- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06890104
Effects of Mechanical, Chemical, and Combination Methods on Halitosis
The Effectiveness of Mechanical and Chemical Measures in Controlling Halitosis in the Buddhist Monastic Populations
Goal:
The goal of this clinical trial is to evaluate the effectiveness of different oral hygiene methods (tooth brushing, tongue cleaning, and mouthwash use) in managing halitosis (bad breath) in adults. The main questions it aims to answer are:
Do oral hygiene methods (tongue cleaning, chlorhexidine mouthwash, and coconut oil mouthwash) reduce the levels of volatile sulfur compounds (VSCs) in participants' breath?
Do these methods improve self-reported and clinically assessed halitosis?
Study Design:
Researchers will compare three intervention groups:
Group I: Tongue cleaning. Group II: Chlorhexidine mouthwash. Group III: Coconut oil mouthwash.
After one week, Groups II and III will add tongue cleaning, and in the third week, Groups I and III will use chlorhexidine mouthwash to ensure equitable benefits.
Participants will:
Follow their assigned oral hygiene regimen daily for 2 weeks. Receive the halitosis assessments at baseline, 1 week, and 2 weeks post-intervention, including organoleptic testing and volatile sulfur compounds level measurements using the OralChroma device.
Complete self-reported assessments of halitosis using a visual analog scale (VAS).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hue, Vietnam
- Faculty of Odonto-Stomatology, Hue University of Medicine and Pharmacy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: Participants must be 18 years or older.
Diagnosis of Halitosis:
- Clinically diagnosed halitosis with an Organoleptic Test (OT) score ≥ 2, AND
- Volatile sulfur compound (VSC) levels exceeding:
Hydrogen sulfide (H2S) > 1.5 ng/10 ml, OR Methyl mercaptan (CH3SH) > 0.5 ng/10 ml.
- Study Population: Buddhist monks and nuns from selected temples in Hue City, Vietnam, to control for dietary and lifestyle factors.
- Willingness to Participate: Participants must provide informed consent and agree to follow the study protocol.
Exclusion Criteria:
- Systemic Diseases: Presence of systemic conditions such as diabetes, gastrointestinal disorders, respiratory disorders, or cancer that could contribute to halitosis.
- Nonoral Causes of Halitosis:Halitosis suspected or confirmed to be caused by gastrointestinal or respiratory diseases.
- Medication Use: Use of antibiotics or other medications within 1 month prior to or during the study period.
Dental Conditions:
- Presence of dental prostheses or orthodontic appliances.
- Untreated open caries lesions or deep periodontal pockets (> 6 mm).
- Allergies: Known allergies to any of the study interventions (e.g., chlorhexidine or coconut oil).
- Lifestyle Factors: Smoking or betel nut chewing habits.
- Inability to Comply: Inability or unwillingness to follow the study protocol or attend follow-up visits.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Tongue brushing
|
|
|
Active Comparator: Mouthrinse with Chlorhexidine 0.12%
|
Using mouthrinse with 0.12% chlorhexidine for two weeks to treat halitosis
|
|
Experimental: Mouthrinse with Coconut oil pulling
|
Using mouth rinse with coconut oil for two weeks to treat halitosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reduction in Volatile Sulfur Compounds (VSCs) Levels
Time Frame: Baseline, 1 week post-intervention, and 2 weeks post-intervention.
|
Measurement of VSC levels (hydrogen sulfide [H2S] and methyl mercaptan [CH3SH]) in participants' breath using the OralChroma device.
Lower VSC levels indicate improved halitosis control.
|
Baseline, 1 week post-intervention, and 2 weeks post-intervention.
|
|
Improvement in Organoleptic Test (OT) Scores
Time Frame: Baseline, 1 week post-intervention, and 2 weeks post-intervention.
|
Clinical assessment of halitosis severity using the Organoleptic Test, where a trained examiner scores breath odor on a scale of 0 (no odor) to 5 (extremely strong odor).
A reduction in OT scores indicates improvement in halitosis.
|
Baseline, 1 week post-intervention, and 2 weeks post-intervention.
|
|
Improvement in Self-Reported Halitosis Severity
Time Frame: Baseline, 1 week post-intervention, and 2 weeks post-intervention.
|
Participants' self-assessment of halitosis severity using a visual analog scale (VAS) ranging from 0 (no bad breath) to 100 (very severe bad breath).
Lower scores indicate improved self-perceived halitosis.
|
Baseline, 1 week post-intervention, and 2 weeks post-intervention.
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H2023/135
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Halitosis
-
Hadassah Medical OrganizationCompleted
-
Çankırı Karatekin UniversityCompleted
-
Church & Dwight Company, Inc.CompletedOral Malodor (Halitosis)United States
-
University of Nove de JulhoCompleted
-
New York Head & Neck InstituteOhio State University; Biolase IncCompleted
-
University of British ColumbiaWithdrawn
-
Tokyo Medical and Dental UniversityCompleted
-
Universitaire Ziekenhuizen KU LeuvenGaba International AGUnknown
Clinical Trials on Mouthrinse with Chlorhexidine 0.12%
-
University of OsloUnknown
-
University of OsloGöteborg UniversityCompletedDental Caries | Periodontal Disease
-
GlaxoSmithKlineCompleted
-
St. Louis UniversityTriumph PharmaceuticalsCompletedPeriodontitis | GingivitisUnited States
-
University of MilanCompleted
-
Universiti Sains Islam MalaysiaCompletedPlaque Accumulation | Patient AcceptanceMalaysia
-
Cairo UniversityNot yet recruitingTeeth Staining | Numbness of the Tongue and Soft Tissue | Bitter Taste
-
Zhejiang UniversityCompletedOral Mucositis | Stem Cell Transplant ComplicationsChina
-
Technische Universität DresdenCompletedDiscoloration of TeethGermany
-
Biointelligent Technology Systems SLCompleted